These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1619078)

  • 21. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
    Stine KC; Saylors RL; Williams LL; Becton DL
    Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Goh NS; McDonald CE; MacGregor DP; Pretto JJ; Brodie GN
    Respirology; 2003 Mar; 8(1):91-4. PubMed ID: 12856748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Langerhans cell histiocytosis--evolution and current approaches.
    Ladisch S; Gadner H
    Br J Cancer Suppl; 1994 Sep; 23():S41-6. PubMed ID: 8075005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral, skin and bone multisystem Langerhans cell histiocytosis and its response to etoposide--a case report.
    Sheehan MP; Chu AC
    Clin Exp Dermatol; 1991 Nov; 16(6):463-6. PubMed ID: 1806325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Langerhans cell histiocytosis.
    Chu T
    Australas J Dermatol; 2001 Nov; 42(4):237-42. PubMed ID: 11903153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
    Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
    Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
    Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine A therapy for multisystem langerhans cell histiocytosis.
    Minkov M; Grois N; Broadbent V; Ceci A; Jakobson A; Ladisch S
    Med Pediatr Oncol; 1999 Nov; 33(5):482-5. PubMed ID: 10531573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone.
    Körholz D; Janssen G; Göbel U
    Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vulvar ulcer as a presentation of systemic Langerhans cell histiocytosis.
    Madnani NA; Khan KJ
    Indian J Dermatol Venereol Leprol; 2011; 77(2):177-9. PubMed ID: 21393948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine.
    Eckstein OS; Bernhardt MB; Hood CG; Karri V; Kralik SF; McClain KL
    Pediatr Hematol Oncol; 2023; 40(5):497-505. PubMed ID: 36625721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma].
    Szturz P; Adam Z; Rehák Z; Koukalová R; Kodet R; Nebeský T; Neubauer J; Moulis M; Smardová L; Mayer J
    Vnitr Lek; 2010 Nov; 56(11):1177-93. PubMed ID: 21250497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
    Pedrol E; Estruch R; Marrades RM; Ingelmo M
    Rev Clin Esp; 1991 Apr; 188(6):319. PubMed ID: 1780535
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 36. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
    Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
    Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB; Xue HM; Chen YY; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide.
    Sander CS; Kaatz M; Elsner P
    Dermatology; 2004; 208(2):149-52. PubMed ID: 15057007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.